David Wilks

2.1k total citations · 1 hit paper
36 papers, 1.5k citations indexed

About

David Wilks is a scholar working on Epidemiology, Infectious Diseases and Virology. According to data from OpenAlex, David Wilks has authored 36 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 9 papers in Infectious Diseases and 6 papers in Virology. Recurrent topics in David Wilks's work include Fibromyalgia and Chronic Fatigue Syndrome Research (6 papers), HIV Research and Treatment (6 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). David Wilks is often cited by papers focused on Fibromyalgia and Chronic Fatigue Syndrome Research (6 papers), HIV Research and Treatment (6 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). David Wilks collaborates with scholars based in United Kingdom, United States and Italy. David Wilks's co-authors include Michael Sharpe, Kimberley Goldsmith, Peter D. White, Gabrielle Murphy, Trudie Chalder, Mary Burgess, Paul McCrone, D. L. Cox, Laura Potts and Lucy Clark and has published in prestigious journals such as The Lancet, Hepatology and Clinical Infectious Diseases.

In The Last Decade

David Wilks

35 papers receiving 1.4k citations

Hit Papers

Comparison of adaptive pacing therapy, cognitive behaviou... 2011 2026 2016 2021 2011 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Wilks United Kingdom 15 804 364 264 233 143 36 1.5k
Mark Sullivan United States 21 446 0.6× 150 0.4× 238 0.9× 452 1.9× 130 0.9× 37 2.0k
Abraham Morag Israel 19 289 0.4× 132 0.4× 557 2.1× 63 0.3× 312 2.2× 57 2.3k
David W. Niebuhr United States 23 294 0.4× 94 0.3× 406 1.5× 135 0.6× 402 2.8× 75 2.6k
Anthony C. Segreti United States 15 940 1.2× 69 0.2× 663 2.5× 124 0.5× 102 0.7× 27 2.3k
Susan E. Bennett United States 25 281 0.3× 138 0.4× 253 1.0× 41 0.2× 23 0.2× 55 1.5k
James M. Smith United States 23 172 0.2× 91 0.3× 148 0.6× 62 0.3× 90 0.6× 64 1.9k
Mary Margaretten United States 18 150 0.2× 113 0.3× 169 0.6× 68 0.3× 106 0.7× 27 1.6k
Mark A. Goldstein United States 29 229 0.3× 197 0.5× 500 1.9× 29 0.1× 62 0.4× 81 2.5k
Benjamin Ing‐Tiau Kuo Taiwan 20 185 0.2× 57 0.2× 157 0.6× 73 0.3× 49 0.3× 40 1.2k
Joep M.D. Galama Netherlands 8 503 0.6× 305 0.8× 189 0.7× 143 0.6× 31 0.2× 11 1.4k

Countries citing papers authored by David Wilks

Since Specialization
Citations

This map shows the geographic impact of David Wilks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Wilks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Wilks more than expected).

Fields of papers citing papers by David Wilks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Wilks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Wilks. The network helps show where David Wilks may publish in the future.

Co-authorship network of co-authors of David Wilks

This figure shows the co-authorship network connecting the top 25 collaborators of David Wilks. A scholar is included among the top collaborators of David Wilks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Wilks. David Wilks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Charlier, Caroline, Ingólfur Johannessen, Claire L. Mackintosh, et al.. (2017). International infectious diseases teaching to undergraduate medical students: A successful European collaborative experience.. PubMed. 39(9). 981–986.
2.
Innes, Hamish, Scott McDonald, Peter Hayes, et al.. (2016). Mortality in hepatitis C patients who achieve a sustained viral response compared to the general population. Journal of Hepatology. 66(1). 19–27. 38 indexed citations
3.
White, Peter D., Kimberley Goldsmith, AL Johnson, et al.. (2011). Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. The Lancet. 377(9768). 823–836. 628 indexed citations breakdown →
4.
Leiding, Jennifer W., B. E. Marciano, Virgil L. Anderson, et al.. (2011). Corticosteroid Therapy for Liver Abscess in Chronic Granulomatous Disease. Clinical Infectious Diseases. 54(5). 694–700. 39 indexed citations
5.
Beadles, Wendy, David Wilks, & Hannah Monaghan. (2007). Fallopian tube carcinoma associated with schistosomiasis. Journal of Infection. 55(5). e121–e123. 6 indexed citations
6.
Haeney, M R, et al.. (2002). The role of fear of physical movement and activity in chronic fatigue syndrome. Journal of Psychosomatic Research. 52(6). 485–493. 95 indexed citations
7.
Hardt, J., Dedra Buchwald, David Wilks, et al.. (2001). Health-related quality of life in patients with chronic fatigue syndrome. Journal of Psychosomatic Research. 51(2). 431–434. 72 indexed citations
8.
Wilks, David, et al.. (2001). Pancreatic Mass caused by Mycobacterium tuberculosis with Reduced Drug Sensitivity. Journal of Infection. 42(3). 201–202. 6 indexed citations
9.
Wilks, David, et al.. (2001). Localized papular cutaneous schistosomiasis: two cases in travellers. Clinical and Experimental Dermatology. 26(1). 50–52. 12 indexed citations
10.
Wilks, David, et al.. (1999). Comparison of Euroqol EQ-5D and SF-36 in patients with chronic fatigue syndrome. Quality of Life Research. 8(1-2). 9–16. 81 indexed citations
11.
Wilks, David & S. M. Burns. (1998). Myopericarditis associated with parainfluenza virus type 3 infection. European Journal of Clinical Microbiology & Infectious Diseases. 17(5). 363–365. 10 indexed citations
12.
Wilks, David, et al.. (1998). Oral histoplasmosis: a case report. Journal of Infection. 37(1). 73–75. 11 indexed citations
13.
Wilks, David & S. M. Burns. (1998). Myopericarditis Associated with Parainfluenza Virus Type 3 Infection. European Journal of Clinical Microbiology & Infectious Diseases. 17(5). 363–365. 1 indexed citations
14.
Wilks, David, S. Kim Jacobson, Andrew Lever, & M. Farrington. (1994). Fatal melioidosis in a tourist returning from Thailand. Journal of Infection. 29(1). 87–90. 13 indexed citations
15.
McCallum, Stewart W., et al.. (1993). THE DIFFERENTIAL EXPRESSION OF HEAT SHOCK PROTEINS IN RHEUMATIC DISEASE. Lara D. Veeken. 32(10). 883–892. 11 indexed citations
16.
Walker, Laura M., et al.. (1992). Localized Conformational Changes in the N-Terminal Domain of CD4 Identified in Competitive Binding Assay of Monoclonal Antibodies and HIV-1 Envelope Glycoprotein. AIDS Research and Human Retroviruses. 8(6). 1083–1090. 9 indexed citations
17.
Wilks, David & Angus Dalgleish. (1992). Anti-idiotypic therapeutic strategies in HIV infection. PubMed. 1. 283–308. 2 indexed citations
18.
Wilks, David, L Walker, J A Habeshaw, A. D. B. Webster, & Angus Dalgleish. (1991). Antiidiotypic Responses to Immunization with Anti-Leu 3a in Human Immunodeficiency Virus-Seropositive Individuals. The Journal of Infectious Diseases. 163(2). 389–392. 7 indexed citations
19.
Wilks, David, L Walker, J A Habeshaw, et al.. (1990). Anti-CD4 autoantibodies and screening for anti-idiotypic antibodies to anti-CD4 monoclonal antibodies in HIV-seropositive people. AIDS. 4(2). 113–118. 24 indexed citations
20.
Wilks, David, N.A. Byrom, Lori A. Walker, J A Habeshaw, & Angus Dalgleish. (1990). Characteristic immunophenotyping artefact seen in patients with anti‐mouse immunoglobulin antibodies. Cytometry. 11(2). 318–319. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026